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Abstract 
Background: Haematology reference values are needed to interpret haematology results and make clinical deci-
sions, but these have not been established for old people in sub-Saharan Africa. The objective of this study was to 
establish haematology reference values for people aged 50 years and above in Uganda, to compare the haematology 
reference values for those aged 65 years and over with those less than 65 years and to compare these haematology 
reference values with established haematology reference values for old people from high income countries.
Methods: A total of 1449 people aged 50 years and above were recruited from the Medical Research Council/
Uganda Virus Research Institute general population cohort between January 2012 and January 2013 (response rate 
72.3 %). From the blood samples collected, we did haematology, HIV testing and malaria tests. We also obtained stool 
samples and tested them for hookworm infection. Questionnaire data were obtained through interviews. In the analy-
sis, we excluded those with HIV infection, malaria infection, hookworm infection and those not feeling well at the time 
of recruitment. Medians and reference ranges for 12 haematology parameters were determined, based on the Clinical 
Laboratory and Standards institute’s guidelines.
Results: In total, 903 people aged 50 years and above were included in the analysis with the majority 545 (60.3 %) 
being female. Men had significant difference in median haemoglobin, haematocrit, erythrocytes counts and white 
blood cells counts, which were higher than those of women. Women had significant difference in mean platelet 
counts and neutrophil percentages which were higher than those of men. Comparing those aged 65+ and those 
aged less than 65 years, the following parameters were significantly lower in those aged above 65 years: haemoglo-
bin, haematocrit, erythrocytes counts, platelets and mean corpuscular volume. Compared to the reference intervals 
from old people in high income countries, all the haematology parameters from our study population were low.
Conclusion: The differences between haematology reference ranges in old people compared to adults and the very 
old (65+) compared to those between 50 and 65 call for more population based studies using nationwide surveys to 
be carried out among old people in other study settings in Uganda and the rest of Africa to explore the differences in 
haematology reference ranges between these different age groups with a view of establishing whether there is need 
to have separate reference range for these different categories of old people.
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Background
Haematology reference values are important in identify-
ing abnormal blood results and for guiding clinicians in 
the management of patients with disorders of the blood 
and other illnesses. In Uganda, like most other African 
countries that do not have locally established haema-
tology reference values for haemoglobin and full blood 
counts, the reference values used for haematology param-
eters are those derived from data collected from white 
people of from high income countries [1, 2]. In addition, 
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these haematology reference values from studies in white 
people are also used to make guidelines, such as those of 
the WHO, used in the definition of anaemia [3].
Haematology reference values derived from white peo-
ple may be different from those derived from black peo-
ple in Africa, as shown by studies conducted in Africa [1, 
2, 4–6]. Generally, reference values for haemoglobin in 
black Africans are lower than those in white people while 
those for platelets are higher than those in white people. 
A number of factors have been suggested for these dif-
ferences, including genetic variation, the higher preva-
lence of pathogens like malaria and hookworm in Africa, 
poorer nutritional status of individuals and altitude [7].
In addition to the question of whether reference val-
ues based on whites are generalisable to other popula-
tions, there is also debate on whether haemoglobin and 
other haematology reference values derived from young 
adults are suitable for old people [8]. For example regard-
ing haemoglobin, a number of studies conducted in high 
income countries have shown that haemoglobin declines 
with age especially in males as compared to females [9–
11]. It has been suggested that there may be some age- 
related conditions that may determine the reduction of 
haemoglobin, such as: reduction in the reserve of haema-
topoietic progenitors, decreased responsiveness of these 
progenitors to stimulatory growth factors and reduced 
erythropoietin production [12], which may contribute 
or result to lower reference ranges for haemoglobin in 
healthy older adults compared to healthy younger adults. 
Such age related differences in haematological reference 
ranges have been reported in high income countries [13, 
14].
From our literature search, we did not come across any 
study from Uganda on haematology reference ranges 
for old people. We identified four studies that were con-
ducted in Uganda on haematology and other laboratory 
reference ranges like CD4 cell counts and blood bio-
chemistry [1, 4, 5, 15] in young adults. All these studies, 
except one, were conducted in preparation of HIV vac-
cine trials. These studies included very few old people 
(<2 %). More importantly, these studies did not test the 
study participants for some infections like malaria and 
hookworm infestations which are prevalent in Uganda 
and have been shown to be related to anaemia, so that 
the reference ranges derived from these studies may 
not reflect the actual reference ranges of healthy peo-
ple within these populations. Studies done elsewhere 
in Africa to establish local haematology and biochemi-
cal reference values have also not targeted older people 
[2, 16–19] with the exception of one study conducted in 
Zimbabwe [20].
Since the population of older people is increasing 
in Africa [21] and research and care for older people 
infected with HIV/AIDS especially those on anti-retro-
viral therapy (ART) is gaining momentum [22, 23], it is 
necessary to establish local haematology reference ranges 
for older people in order to improve on the interpretation 
of haematology results for older people.
We used data from the anaemia survey that was con-
ducted in older people in the General Population Cohort 
(GPC) in rural South West Uganda to create haematology 
reference ranges for old people including hemoglobin, 
white blood cell counts (WBC) totals and differentials, 
red blood cell counts (RBC), haematocrit (HCT), mean 
corpuscular volume (MCV), mean corpuscular hemo-
globin (MCH) and platelets (PLT). We compared haema-
tology reference ranges for people aged 50 to ≤65 years 
and those aged  >65  years and compared these refer-
ence ranges with those reported from old people in high 
income countries [13, 14, 24, 25].
Methods
Study population
Study participants aged 50  years and above were 
recruited during the anaemia survey that was conducted 
in the General Population Cohort [26] round 23 between 
January 2012 and January 2013. Eligible participants were 
elder residents that gave consent to participate in the 
study from 25 study villages during the survey period, 
were willing to give a blood and stool sample and were 
willing to be interviewed. Participants were excluded if 
they were too ill to answer questions.
Justification for inclusion of 50–59 age groups
There are many definitions that have been used to 
describe older people. However, there is no general 
agreement on the age at which a person becomes old, 
although generally they can refer to people aged 60 years 
and over [27]. In many developed countries, the ref-
erence age can be pushed up to 65, which is the age at 
which people become eligible for old age social security 
benefits [28]. In sub Saharan Africa, it is acceptable to use 
50 years old as a cut off as previously defined by the mini-
mum data set project [29] of the World Health Organisa-
tion, due to the low life expectancy in this region.
The general population cohort
Details of the general population cohort have been 
described previously [30]. In brief, the GPC is a popula-
tion-based cohort study of around 20,000 people living 
within the Kyamulibwa sub-county of Kalungu district in 
rural South-West Uganda. The cohort was established in 
1989 by MRC/UVRI Uganda Research Unit on AIDS to 
describe trends in the prevalence and incidence of HIV 
infection and their determinants in the general popula-
tion. The initial recruitment was conducted in 1989/1990.
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Every year since 1989, annual house-to-house “rounds” 
of census and survey have been carried out until 2012 
when the house to house survey method was changed to 
active participation by inviting and surveying residents at 
central hubs (a building rented for the purpose in the vil-
lage) in each of the study villages.
Demographic, socio-medical and serological data are 
collected. Information regularly obtained includes data 
on fertility, mortality, migration, sexual behavior, percep-
tions of HIV infection and HIV status.
The GPC runs a clinic and a clinical laboratory at the 
Kyamulibwa field office where GPC participants can 
access free treatment. The clinic is run by two clini-
cians and is stocked with most of the essential drugs 
recommended by the Ministry of Health of the Uganda 
government.
In addition to conducting annual HIV sero surveys, 
the GPC also provides a population for recruitment for 
other studies including the rural clinical cohort aimed 
at understanding the clinical course of HIV disease 
in adults and improving treatment outcomes for HIV 
infected participants and social science research aimed 
at an in-depth understanding of social aspects of health, 
including research on the health and wellbeing of older 
people.
The study reference population has prevalent diseases 
like malaria, worm infestations especially hookworm, 
HIV/AIDS and a number of respiratory tract infections.
Data collection for the anaemia survey
A questionnaire for the anaemia study was developed 
based on existing questions in the GPC survey question-
naire [26], the World Health Organisation study on global 
ageing and adult health [31] questionnaire and the cross 
cultural assessment of nutrition in older subjects ques-
tionnaire [32]. For this analysis, we collected questions 
specifically on the social demographic characteristics of 
study participants, alcohol and tobacco use, self-rated 
health at the time of the interviews, history of fever, use 
of drugs for malaria treatment in the past month prior 
to the interview, history of worm treatment in the past 
month prior to the interview and history of cancer or 
cancer treatment. The anaemia study questionnaire was 
translated into the local language and back translated 
into English and necessary adjustments made. The ques-
tionnaire was then pilot tested using 63 people belong-
ing to the target age group. The final questionnaire was 
then programmed on ultra-mobile personal computers 
(UMPCs) which were used for data collection. All older 
people in the GPC were first enumerated and mobilized 
through community meetings, and home visits. Those 
that consented to participate in the anaemia survey were 
either interviewed from the village central hubs or were 
interviewed from the GPC study clinic. All interviews 
were conducted by trained interviewers from the GPC.
Sample collection
Phlebotomy was performed by a nurse on one arm 
with the respondent in the seated position. Five millilit-
ers of blood were drawn in an EDTA tube and inverted 
5–6 times to ensure mixing with EDTA anticoagulant 
to prevent clotting. Blood samples were drawn between 
8.30 a.m. and 2.30  p.m. each day. Participants did not 
undergo fasting prior to phlebotomy. Two consecutive 
stool samples were obtained in stool bottles which had 
been provided together with instructions a day prior to 
the interview. The samples were stored in cold boxes and 
transported on the same day to the Kyamulibwa clinic 
laboratory by an MRC/UVRI van.
Haematology
A complete blood count with a differential was per-
formed on the on the same day the sample was collected. 
The haematology was performed at the Kyamulibwa clin-
ical laboratory using a Beckman Coulter AC.T 5 diff CP 
Haematology analyser (Beckman Coulter, USA), follow-
ing the manufacturer’s instructions.
HIV testing
HIV testing was done using an algorithm for HIV-test-
ing with three HIV-1 rapid tests as recommended by the 
Uganda Ministry of Health. The algorithm for HIV rapid 
testing consisted of an initial screening with the rapid 
test Determine HIV1/2 (Abbot Laboratories by Abbot 
Japan, CO LTD, Minato-Ku, Tokyo Japan). If the test 
result was negative the participant was given a diagnosis 
of HIV negative with no further rapid testing. If the test 
result was positive the sample was retested with the rapid 
test HIV 1/2 Stat-Pak (Chembio Diagnostics System 3661 
Horseblock Road, Med Ford, New York 11763, USA). If 
both tests gave a positive result the participant was given 
a diagnosis of HIV positive with no further rapid testing. 
If the tests gave discordant results (one positive and the 
other negative), the sample was further evaluated with 
the rapid test Uni-Gold Recombinant HIV-1/2 (Trinity 
Biotech PLC, IDA Business Park, Bray, Cowicklow, Ire-
land). For those samples assessed by all three tests, two 
positive test results were interpreted as a positive diagno-
sis. If two of the three tests gave negative results then the 
participant was diagnosed as being negative for HIV.
Malaria testing
Malaria was defined as having a positive blood slide for 
malaria parasites. Thick and thin, Giemsa-stained blood 
smears were prepared and microscopically examined for 
malaria parasite and species.
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Hookworm testing
Two slides per stool sample were prepared at the Kyam-
ulibwa clinical laboratory and examined for hook worm 
ova using the Kato Katz method [33]. Results were clas-
sified based on WHO infection guidelines as light [less 
than 2000 eggs per g (EPG) of faeces], moderate (between 
2000 and 4000 EPG) and heavy (above 4000 EPG).
Quality control
All laboratory tests were performed by trained labora-
tory technologists following special operating procedures 
of the MRC/UVRI laboratories. External quality assur-
ance for the MRC/UVRI laboratories was also carried 
out every year by National Health Laboratory Services 
(South Africa) and Royal College Pathologists Australia 
for the automated machines twice a year. In addition to 
these, laboratory audits were conducted on the MRC/
UVRI laboratories twice a year by Clinical Laboratory 
services South Africa and Qualogy Ltd for good clinical 
laboratory practice annually. Controls for the haematol-
ogy analyser were done on a daily basis using commer-
cially manufactured COULTER AC.T5 diff control plus 
(Beckman Coulter, USA) and were classified as low, nor-
mal and high.
Ethical considerations
Ethical clearance was obtained from London School 
of Hygiene and Tropical Medicine ethics committee, 
Uganda Virus Research Institute Research and Ethics 
Committee and the Uganda National Council for Science 
and Technology. We obtained informed consent from all 
the study participants and all participants requiring med-
ical treatment were referred to the GPC study clinic and 
nearby government health centres.
Data management and statistical methods
Questionnaire data were uploaded from the UMPCs onto 
a networked computer and automatically stored onto the 
server each evening at the MRC/UVRI field station. The 
following morning, the data were checked and uploaded 
onto the database. Laboratory data were double entered 
into access computer program by data entry officers at 
the field station. After data cleaning (looking for miss-
ing values, removing extreme values and wrong entries), 
questionnaire data were merged with laboratory data. 
Data analysis was performed using STATA 11 software 
(Stata Corp, College Park, TX, USA). In the analysis we 
excluded participants with malaria, hookworm, HIV/
AIDS or those who reported that they were not feeling 
well at the time of the survey. Since most of the litera-
ture on haematology reference intervals has shown dif-
ferences between men and women, we stratified the data 
by gender. We also stratified the data by age (comparing 
older people 50–65 years and those 65 years and above). 
All analysis for establishing the reference values were 
based on the CLSI (Clinical and Laboratory Standards 
Institute, 2008) [34].
We first performed a goodness of fit test. Since most 
of the parameters were not normally distributed accord-
ing to the Shapiro–Wilk test for normality, we used a 
non-parametric method as a procedure for establishing 
reference values [34]. With respect to outliers, we used 
Dixons method [35]. Medians and reference values were 
obtained directly from the data and p values for the dif-
ferences between men and women were estimated using 
the Mann–Whitney test. The reference values were cal-
culated as the range between those values at the 2.5 and 
97.5  % limits for the population. The reference values 
thus encompassed 95 % of our study population.
Results
Description of study population and exclusions
In total, questionnaire and haematology data were availa-
ble for 1455 participants (72.3 % of the total population of 
older people within the GPC). More than half (58.2 %) of 
the participants interviewed were female (Table 1). After 
excluding those with hookworm infection (412), current 
malaria infection (41), those who were HIV positive (94), 
and those who were uncertain about their age (5) we had 
data for 903 older people (62.1 %) of which 545 (60.3 %) 
were female (Table 2).
Haematology values for older people
The 95  % reference ranges for haematology in people 
aged 50 years and above are shown in Table 2. Only hae-
moglobin, haematocrit, erythrocyte counts white blood 
cells counts, platelet counts and neutrophil percent, were 
significantly different for men as compared to women 
(p  <  0.05). Men had higher haemoglobin, haematocrit, 
erythrocyte counts and white blood cell counts than 
women. Women had higher platelet counts and higher 
neutrophils.
Haemalotogy reference values in those below and 
above 65 years
The 95  % reference values for ≤65  years and those  >65 
according to gender are shown in Table 3. The following 
parameters were significantly lower in those aged above 
65  years compared with those aged less than 65  years: 
haemoglobin, haematocrit, erythrocytes, platelets and 
mean corpuscular volume.
Comparison with haematology values in old people
We only identified one study from the African region 
on haematology reference ranges for old people there-
fore; the comparisons were from studies undertaken in 
Page 5 of 9Mugisha et al. BMC Res Notes  (2016) 9:433 
high income countries. Most of the studies used differ-
ent methodologies, with some reporting haematology 
reference ranges as 2.5th to 97.5th percentiles and some 
as mean  ±2 SD. Table  4 shows haematology reference 
ranges in our study compared to other studies conducted 
in high income countries. All haematology parameters 
in our study were lower than those reported in literature 
[24, 36] except for a study conducted in China, where old 
people had MCV values that were lower than those in 
our study.
Discussion
Using blood samples drawn from older people in the 
anaemia survey, we established haematology reference 
ranges for parameters including haemoglobin, haemato-
crit, erythrocytes, WBC counts, platelets, mean corpus-
cular haemoglobin, mean corpuscular volume: number 
and percentages for lymphocyte, monocyte, eosinophil 
and basophil. We compared haematology reference val-
ues for old people aged above 65 years with those below 
65 years.
Table 1 Description of  study participants in  the anaemia 
survey
a Missing marital status for 1 male and 1 female
b SES score computed from asset index based on household ownership of items 
within the study setting missing data for 98 males and 96 females
c Missing data on chewing tobacco for 1 female
d Missing data on BMI for 6 males and 16 females
e Missing data on HIV for 3 males and 5 females
Males
(N = 605)
Females
(N = 844)
Age (years)
 50–59 257 (43 %) 344 (40.8 %)
 60–69 155 (26 %) 291 (34.5 %)
 70–79 138 (23 %) 149 (17.7 %)
 80+ 55 (9 %) 60 (7.1 %)
Marital statusa
 Married 427 (70.7 %) 276 (32.7 %)
 Divorced/separated 115 (19.0 %) 218 (25.9 %)
 Widowed 53 (8.8 %) 346 (41.0 %)
 Single (never married) 9 (1.5 %) 3 (0.4 %)
Education level
 None/incomplete primary 125 (20.7 %) 281 (33.3 %)
 Primary 372 (61.5 %) 500 (59.2 %)
 Secondary 90 (14.9 %) 45 (5.3 %)
 Above secondary 18 (3.0 %) 18 (2.1 %)
SES score tertileb
 Low 186 (36.7 %) 253 (33.8 %)
 Middle 175 (34.5 %) 294 (39.3 %)
 High 146 (28.8 %) 201 (26.9 %)
Smoking
 Current smoker 188 (31.1 %) 36 (4.3 %)
 Past smoker 153 (25.3 %) 31 (3.7 %)
 Never smoked 264 (43.6 %) 777 (92.0 %)
Chewing tobaccoc
 Current user 112 (18.5 %) 184 (21.8 %)
 Past regular user 6 (1.0 %) 12 (1.4 %)
 Never regular user/never used 487 (80.5 %) 647 (76.7 %)
Alcohol consumption
 Current drinker 373 (61.7 %) 315 (37.3 %)
 No drinking in past year 100 (16.5 %) 221 (26.2 %)
 Never drinker 132 (21.8 %) 308 (36.5 %)
BMI (kg/m2)d
 Underweight (<18.5) 182 (30.4 %) 133 (16.1 %)
 Normal (18.5–24.9) 379 (63.3 %) 515 (62.2 %)
 Overweight (25.0–29.9) 37 (6.2 %) 134 (16.2 %)
 Obese (≥30) 1 (0.2 %) 46 (5.6 %)
Blood pressure group
 Normal 170 (28.1 %) 222 (26.3 %)
 Pre-hypertension 214 (35.4 %) 299 (35.4 %)
 Stage I hypertension 152 (25.1 %) 191 (22.6 %)
 Stage II hypertension 69 (11.4 %) 132 (15.6 %)
HIV serostatuse
 Negative 554 (92.0 %) 793 (94.5 %)
 Positive 48 (8.0 %) 46 (5.5 %)
Table 2 Haematology reference ranges [median (95th-per-
centile)] derived from older people in rural Uganda
Sample of haematology reference ranges excluding those with hookworm 
infection, malaria infection, HIV infection and those uncertain of their age
a Analytes significantly different by sex
Analyte (param-
eter)
All participants
N = 903
Male
N = 358
Female
N = 545
Hemoglobin (g/
dL)a
13.6 (10.9–15.8) 14.2 (10.6–16.4) 13.3 (11.0–15.0)
Haematocrit (%)a 40.6 (32.5–47.3) 42.2 (32.4–49.1) 39.8 (32.7–45.4)
Erythrocytes 
(10/L)a
4.63 (3.60–5.60) 4.7 (3.6–5.7) 4.6 (3.7–5.4)
Platelets (109/L)a 220 (77–353) 207 (60–336) 229 (98–359)
WBC (×1000) 4.8 (3.0–7.7) 4.9 (3.2–7.8) 4.8 (3.0–7.2)
MCH (pg) 29.4 (25.0–33.4) 30.0 (24.7–34.2) 29.1 (25.0–32.6)
MCV (fL) 87 (75–99) 89 (73–102) 87 (76–97)
MCHC (g/L) 33.4 (32.0–35.2) 33.5 (32.0–35.2) 33.4 (32.1–35.2)
Neutrophils (no 
109/L)
2.05 (1.05–3.78) 2.04 (1.05–4.40) 2.05 (1.05–3.60)
Neutrophils (%)a 43.0 (27.2–60.3) 42.5 (26.0–62.4) 43.5 (28.1–58.5)
Lymphocytes (no 
109/L)
2.09 (1.15–3.51) 2.05 (1.20–3.70) 2.1 (1.1–3.4)
Lymphocytes (%) 43.9 (28.6–59.8) 43.6 (27.9–60.8) 44.2 (29.4–59.3)
Monocytes (no 
109/L)
0.31 (0.17–0.57) 0.33 (0.18–0.59) 0.30 (0.17–0.55)
Monocytes (%) 6.5 (4.1–10.7) 6.9 (4.3–12.1) 6.3 (3.9–10.2)
Eosinophils (no 
109/L)
0.15 (0.50–0.81) 0.16 (0.04–0.82) 0.14 (0.05–0.75)
Eosinophils (%) 3.2 (1–15.3) 3.4 (1.0–15.9) 3.0 (1.1–14.5)
Basophils (no 109/L 0.04 (0.02–0.08) 0.04 (0.02–0.08) 0.04 (0.02–0.08)
Basophils (%) 1.0 1.0 1.0
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To the best of our knowledge, this is the first population 
based study, in Uganda to describe reference values for 
haematology in old people. From our literature search, we 
only found one old study which was conducted among old 
Zimbabweans [20]. As research on health issues affecting 
older people takes root in Africa, findings from this study 
will be valuable in identifying old people with haematol-
ogy abnormalities based on locally derived haematology 
reference values for old people. Compared to other stud-
ies conducted in young adults in Uganda [1, 4, 5, 15], we 
excluded all the study participants with malaria which has 
been associated with low haemoglobin, elevated white 
blood cell counts and thrombocytopenia [37]. We also 
excluded participants with hookworm infection and those 
with HIV infection since these have also been strongly 
associated with low haemoglobin values [38, 39].
Overall, old people in our study had lower haemoglo-
bin values compared to other studies conducted in young 
adults in Uganda. However, old women in our study had 
higher haemoglobin values as compared to young adult 
women in Uganda and other East African countries 
[1, 5, 19]. The higher haemoglobin in old women com-
pared to young adult women may be due to the fact that 
old women have passed through menopause and are no 
longer experiencing menstrual blood loss.
Old people above 65  years also had lower haemoglo-
bin and haematocrit values as compared to those below 
65  years. We do not have many studies to compare our 
results for people below 65 because most of the studies 
on haematology reference values conducted among old 
people in high income countries define old people as 
those aged 65  years and above. However, these results 
are in agreement with findings from the Second National 
Health and Nutritional Examination Survey in which 
haematology reference values for those aged 45–64 years 
tended to be higher than those aged 65–74  years [13]. 
Studies conducted elsewhere in high income countries 
have shown that haemoglobin decreases with age, with 
the decline more pronounced in men than women [9, 
40], implying that haemoglobin reference values in old 
people may need to be different from haemoglobin refer-
ence values for young adults.
Haemoglobin, haematocrit, erythrocyte counts, MCV 
and platelet counts tended to be lower in our study than 
in other studies conducted among old people in high 
income countries [13, 14, 24, 25]. Possible explanations 
for these differences could be both genetic and environ-
mental differences between Blacks and the differences in 
nutritional status between old whites and old blacks.
Females 65 years and older had higher platelet counts 
than men. Other studies have also reported these gender 
differences in platelet counts [4, 36].
Although we tried to exclude old people with known 
illnesses associated with low haemoglobin and other 
Table 3 Haematology reference ranges median [(95th-percentile)] comparing those above and below 65 years
a  Analytes significantly different in those aged 65 years and above and those below 65 years
Analyte Male Female
≤65 years
N = 207
>65 years
N = 151
≤65 years
N = 321
>65 years
N = 224
Hemoglobin (g/dL)a 14.5 (11.7–16.6) 13.6 (9.7–15.5) 13.4 (11.1–15) 13.2 (10.8–15)
Hematocrit (%)a 43.2 (35–49.9) 40.9 (29.6–48.1) 40 (33–45.5) 39.6 (32–45)
Erythrocytes (10/L)a 4.8 (3.6–5.8) 4.63 (3.5–5.8) 4.61 (3.8–5.5) 4.6 (3.6–5.3)
Platelets (10/L)a 220 (55–337) 201 (73–334) 222 (105–363) 235 (78–359)
WBC (10/L) 5 (3.3–7.8) 4.8 (2.9–8) 4.8 (3–7) 4.8 (3–7)
MCH (pg) 30.4 (26.1–34.2) 29.5 (23.2–33.8) 29 (24.7–32.6) 29.2 (25.6–32.7)
MCV (fl) 90 (77–102) 88 (71–100) 87 (75–99) 87 (77–97)
MCHC (g/L) 33.6 (32.2–35.4) 33.4 (31.4–35) 33.4 (32.1–35.2) 33.3 (32.1–35.3)
Neutrophils (10/L) 2.03 (1.06–4.6) 2.01 (1.03–3.8) 2.02 (1.08–3.5) 2.1 (1.04–4.1)
Neutrophils (%) 42.7 (25.8–62.2) 41.9 (27.1–63.1) 42.8 (29.5–58.2) 43.6 (27.4–59.9)
Lymphocytes (10/L) 2.13 (1.22–3.63) 1.96 (1.1–3.87) 2.11 (1.2–3.36) 2.09 (1.08–3.48)
Lymphocytes (%) 43.7 (27.8–61.2) 43.5 (27.9–60.1) 44.4 (29.8–58.8) 43.5 (28.8–68.8)
Monocytes (10/L) 0.33 (0.18–0.57) 0.33 (0.19–0.67) 0.29 (0.17–0.54) 0.31 (0.17–0.57)
Monocytes (%) 6.7 (4.3–12.1) 7 (4.5–12.2) 6.2 (3.9–10.3) 6.4 (4–10.2)
Eosinophils (10/L) 0.16 (0.5–0.8) 0.16 (0.04–0.88) 0.14 (.04–0.67) 0.13 (0.05–1.06)
Eosinophils (%) 3.4 (1–15.9) 3.4 (90.9–12.6) 3.1 (1–12.1) 2.9 (1.1–16.2)
Basophils (10/L) 0.04 (0.2–0.08) 0.03 (0.01–0.08) 0.04 (0.02–0.07) 0.04 (0.02–0.09)
Basophils (%) 1 1 1 1
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haematology parameters, old people who were included 
in this study could have had some subclinical-illnesses 
which we were not able to diagnose. We did not exclude 
smokers from our analysis even if smoking is known to 
elevate the total white blood cell count and neutrophils 
[41]. This may have not had greater impact on our find-
ings since a small proportion of older people within the 
GPC smoke, especially the men. Old people in our study 
did not undergo fasting prior to phlebotomy. This may 
have affected some of the parameters. Since we bled par-
ticipants between 8.30 a.m. in the morning and 2.30 p.m. 
in the afternoon, it was not feasible for old people to 
undergo fasting prior to phlebotomy.
From this study, it is clear that the haematology refer-
ence ranges based on those from high income countries 
commonly applied to old people in Uganda may not be 
Table 4 Reference values [median (95th-percentile)] compared with those of other studies in old people
The numbers from these four studies cited are from the original publications
Parameter (analyte) Current study Uganda
(age 50+)
Hale et al. [26]
(USA) 65+
Yip et al. [16]
(USA) 65+
Tsang et al. [17]
(Australia) 49+
Woo et al. [27]
(China) 60+
Mean age (range) 63.5 (50–94)
% Female 60.3
Comorbidities excluded Malaria, HIV, Hookworm
Study design Cross sectional Cross sectional Cross sectional Cross sectional Cross sectional
Hemoglobin (g/dL)
 All 13.6 (10.9–15.8)
 Male 14.2 (10.6–16.4) −(14–18) 14.9 (12.6–17.4) 15.6 (13.1–17.5) 12.1–16.5
 Female 13.3 (11–15) −(12–16) 13.8 (11.7–16.1) 14.3 (12.2–16.1) 10.7–15
Haematocrit (%)
 All 40.6 (32.5–47.3)
 Male 42.2 (32.4–49.1) −(42–52) 44 (37–51) 46 (39–51) 36–49
 Female 39.8 (32.7–45.4) −(37–47) 40.8 (35–47) 42 (36–47) 32–45
Erythrocytes (10/L)
 All 4.63 (3.6–5.6)
 Male 4.7 (3.6–5.7) −(4.7–6.1) 4.82 (3.8–5.8) 5.06 (4.2–5.9) 4.0–5.7
 Female 4.6 (3.7–5.4) −(4.2–5.4) 4.5 (3.8–5.2) 4.7 (4–5.4) 3.8–5.4
Platelets (109/L)
 All 220 (77–353)
 Male 207 (60–336) 240 (153–382) 95–224
 Female 229 (98–359) 269 (163–414) 93–267
WBC (×1000)
 All 4.8 (3–7.7) −(4.8–10.8)
 Male 4.9 (3.2–7.8) 6.4 (3.9–9.5) 4.6–10.5
 Female 4.8 (3–7.2) 6.1 (3.6–9.4) 4.5–11.5
MCV (Fl)
 All 87 (75–99)
 Male 89 (73–102) −(80–94) 91 (81–103) 90 (80–99) 71–96
 Female 87 (76–97) −(81–99) 90 (81–102) 90 (80–97) 70–96
Neutrophils (×109/L) 2.05 (1.05–3.8)
Neutrophils (%) 43 (27.2–60.3)
Lymphocytes (×109/l) 2.09 (1.2–3.5)
Lymphocytes (%) 43.9 (28.6–59.8)
Monocytes (×109/L) 0.31 (0.17–0.57)
Monocytes (%) 6.5 (4.1–10.7)
Eosinophils (×109/L) 0.15 (0.05–0.81)
Eosinophils (%) 3.2 (1–15.3)
Basophils (×109/L) 0.04 (0.02–0.08)
Basophils (%) 1 (0–2)
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appropriate for them. In addition, the haematology refer-
ence ranges for old people in our study had differences 
with the haematology reference ranges derived from old 
people from high income countries. Using appropriate 
haematology reference ranges for old people in Uganda 
will prevent the repetition and additional laboratory and 
clinical procedures that may be performed to old peo-
ple once their haematology results do not fall under the 
commonly used reference ranges. In addition, it will also 
reduce on misclassifying old people participating in clini-
cal trials or any other epidemiological studies as having 
adverse haematology abnormalities.
In conclusion, although we have described the hae-
matology reference ranges for old people using a sample 
derived from a general population, there is also need for 
more population based studies using nationwide surveys 
to be carried out among old people in other study set-
tings in Uganda and the rest of Africa to explore the dif-
ferences in haematology reference values between those 
aged below and above 65  years of age, with a view of 
establishing whether there is need to have separate ref-
erence values for these different categories of old people.
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